Á¦56ȸ ´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-23
±³À°ÀÏÀÚ : 2024-05-23
±³À°Àå¼Ò : ¿©¼ö ¼Ò³ëį È£ÅÚ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ : Á¦56ȸ ´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѼҾƽŰæÇÐȸ
´ã´çÀÚ : ÀÓº´Âù
¿¬¶ôó : 02-2072-2364
À̸ÞÀÏ : prabbit7@snu,ac,kr
±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : Àü¶ó³²µµ
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í Àü¹®ÀÇ 100,000¿ø / Àü°øÀÇ ¹× ±âŸ 50,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 10:00~10:30 Beyond seizure: screening and management of cognitive problems in children with epilepsy ÃÖ¼±¾Æ(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 10:30~11:00 Psychiatric and behavioral adverse events of antiseizure medications in children with epilepsy ±èÁ¸¼ö(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 11:00~11:30 Antiseizure medication withdrawal for self-limitied epilepsy with centrotemporal spikes and childhood absence epilepsy ±ÇÇýÀº(°¡Å縯°üµ¿´ë)
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 11:30~12:00 New insights on epileptogenesis and therapeutic discovery from epilepsy models °ÁØ¿ø(Ãæ³²ÀÇ´ë)
Åä·Ð 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 12:00~12:10 Åä·Ð ( )
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 12:10~12:40 Strategies for increasing the impact of a journal: insights from the Journal of Clinical Neurology ±èº´Á¶(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 12:40~13:10 How to write a medical paper? °ÈÆö(¿¬¼¼ÀÇ´ë)
Åä·Ð 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 13:10~13:20 Åä·Ð ( )
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 13:20~13:50 Central nervous system infections in children ±è¼¼Èñ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 13:50~14:20 Diagnostic challenges and management of autoimmune encephalitis in children À̺¸·Ã(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 14:20~14:50 Recent clinical and biological advances in autoimmune encephalitis ±è¹ÎÁö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 14:50~15:20 Central nervous system lupus ½É¿µ±Ô(°í·ÁÀÇ´ë)
ÈÞ½Ä 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 15:20~15:40 Coffee Break ( )
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 15:40~16:10 Beginning of the era of generative AI and its application in pediatric neurology ¾çµ¿È(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 16:10~16:40 Gentle Introduction to brain connectivity analysis: from Fourier to dynamic causal modeling ±è½Â¼ö(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 16:40~17:10 New biomarkers for pediatric migraine: focusing on calcitonin gene-related peptide ³ªÁöÈÆ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05¿ù 23ÀÏ 1Ãþ ÄÁº¥¼Ç¼¾ÅÍ 17:10~17:40 Antisense oligonucleotide therapy for neurodevelopmental disorders ±èÈ¿Á¤(°¡ÃµÀÇ´ë)